Recent Publications and Bulletins
The objective of the study was to estimate the potential health and economic benefits that may arise due to pharmaceutical interventions in a wide variety of illnesses.
The Ontario government recently announced a 10-year infrastructure plan entitled Building Together. It promises to build upon the long-term approach to infrastructure investment from the previous ReNew Ontario plan. As a result, the awareness of infrastructure investment in Ontario has increased. However, while the public has an intuitive understanding of the importance of infrastructure to the economic prosperity of the province, it is likely that the majority of the population does not fully recognize the personal risks associated with continued underinvestment.
For some time, experts have been warning of a deficit between the current state of Canadian infrastructure and what is required—the so-called “infrastructure gap.” And, while it is well known that the quality and quantity of infrastructure has a direct impact upon how efficiently societies are able to operate and grow, individuals and businesses have yet to connect underinvestment in infrastructure to their personal prosperity. Citing a municipal infrastructure deficit in the billions of dollars sounds staggering, but it may not resonate on a personal level with the public.
Based on the technical report "Rising Tide: The Impact of Dementia in Canada 2008 to 2038" by Smetanin, P; Kobak, P; Briante, C; Stiff, D; Sherman, G; Ahmad, S.
Background:
Antiviral drugs are an effective means to improve the recovery rate and reduce mortalities of people with influenza if the virus is sensitive to the drug. Under widespread use for prophylaxis and treatment with the risk of resistant variants arising, the consequences and cost-effectiveness of antivirals are less certain. The objective of this study was to identify the antiviral strategies that remain effective in both life and cost terms, when the characteristics of an emerging pandemic are unknown.
Background:
The first pandemic of the millennium was declared in June 2009. At that time, the pH1N1 virus was already in circulation in Canada and early reports from around the world indicated a potentially severe pandemic. The initial projections did not materialize but it was not clear whether this was due to the nature of the virus, or the success of public health initiatives. The objective of this analysis was to examine the effectiveness of the interventions used in Canada from both a health and economic point of view.
Background:
The purpose of the current study was to analyze the adequacy of the current Canadian antiviral stockpile during a moderate, drug sensitive influenza pandemic in Canada under three potential interpretations of the Canadian Pandemic Influenza Plan (CPIP).
Due to the capricious nature of a pandemic, the precise impact of a soH1N1 second wave remains largely a matter of speculation. This is a cause of concern for those responsible for coordinating pandemic responses. Dynamic pandemic modelling can assist resource planners that need to adapt to a pandemic as it unfolds. Since early June, a pandemic model has been periodically fit to soH1N1 Canadian data with resulting attack rates ranging between 21% and 29%, peaking generally around late December.
Background:
Cancer currently represents the major burden of disease facing our community. It is the major cause of death, the major cause of premature deaths and the major cause of deaths in the productive age groups 45 to 65 years. The incidence rates have increased by 10 per cent in men and seven per cent in women over the last few years. The exceptions are increasing incidence rates of prostate cancer and decreasing incidence rates of breast cancer. However, the numbers of cancer cases continue to increase.
Pages
